270 related articles for article (PubMed ID: 24076158)
1. Identification of the C/EBPα C-terminal tail residues involved in the protein interaction with GABP and their potency in myeloid differentiation of K562 cells.
Shimokawa T; Nunomura S; Fujisawa D; Ra C
Biochim Biophys Acta; 2013 Nov; 1829(11):1207-17. PubMed ID: 24076158
[TBL] [Abstract][Full Text] [Related]
2. Amino acid residues in the beta3 strand and subsequent loop of the conserved ETS domain that mediate basic leucine zipper (bZIP) recruitment and potentially distinguish functional attributes of Ets proteins.
Shimokawa T; Nunomura S; Enomoto Y; Ra C
Biochem J; 2010 Aug; 430(1):129-39. PubMed ID: 20522024
[TBL] [Abstract][Full Text] [Related]
3. C/EBPalpha functionally and physically interacts with GABP to activate the human myeloid IgA Fc receptor (Fc alphaR, CD89) gene promoter.
Shimokawa T; Ra C
Blood; 2005 Oct; 106(7):2534-42. PubMed ID: 15928042
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
[TBL] [Abstract][Full Text] [Related]
5. Cooperative Activity of GABP with PU.1 or C/EBPε Regulates Lamin B Receptor Gene Expression, Implicating Their Roles in Granulocyte Nuclear Maturation.
Malu K; Garhwal R; Pelletier MG; Gotur D; Halene S; Zwerger M; Yang ZF; Rosmarin AG; Gaines P
J Immunol; 2016 Aug; 197(3):910-22. PubMed ID: 27342846
[TBL] [Abstract][Full Text] [Related]
6. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
[TBL] [Abstract][Full Text] [Related]
7. Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad link.
Zada AA; Pulikkan JA; Bararia D; Geletu M; Trivedi AK; Balkhi MY; Hiddemann WD; Tenen DG; Behre HM; Behre G
Leukemia; 2006 Dec; 20(12):2137-46. PubMed ID: 17082780
[TBL] [Abstract][Full Text] [Related]
8. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding.
Cleaves R; Wang QF; Friedman AD
Oncogene; 2004 Jan; 23(3):716-25. PubMed ID: 14737106
[TBL] [Abstract][Full Text] [Related]
9. Functional interaction of CCAAT/enhancer-binding-protein-α basic region mutants with E2F transcription factors and DNA.
Kowenz-Leutz E; Schuetz A; Liu Q; Knoblich M; Heinemann U; Leutz A
Biochim Biophys Acta; 2016 Jul; 1859(7):841-7. PubMed ID: 27131901
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
[TBL] [Abstract][Full Text] [Related]
11. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
Rangatia J; Vangala RK; Singh SM; Peer Zada AA; Elsässer A; Kohlmann A; Haferlach T; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Jul; 22(30):4760-4. PubMed ID: 12879022
[TBL] [Abstract][Full Text] [Related]
12. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T
Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells.
Fragliasso V; Chiodo Y; Ferrari-Amorotti G; Soliera AR; Manzotti G; Cattelani S; Candini O; Grisendi G; Vergalli J; Mariani SA; Guerzoni C; Calabretta B
J Cell Biochem; 2012 May; 113(5):1704-13. PubMed ID: 22212957
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
15. C/EBP alpha:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBP alpha homodimers or AP-1.
Cai DH; Wang D; Keefer J; Yeamans C; Hensley K; Friedman AD
Oncogene; 2008 Apr; 27(19):2772-9. PubMed ID: 18026136
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle inhibition mediated by the outer surface of the C/EBPalpha basic region is required but not sufficient for granulopoiesis.
Wang QF; Cleaves R; Kummalue T; Nerlov C; Friedman AD
Oncogene; 2003 May; 22(17):2548-57. PubMed ID: 12730669
[TBL] [Abstract][Full Text] [Related]
17. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.
Gombart AF; Hofmann WK; Kawano S; Takeuchi S; Krug U; Kwok SH; Larsen RJ; Asou H; Miller CW; Hoelzer D; Koeffler HP
Blood; 2002 Feb; 99(4):1332-40. PubMed ID: 11830484
[TBL] [Abstract][Full Text] [Related]
19. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.
Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B
Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500
[TBL] [Abstract][Full Text] [Related]
20. A positive regulatory domain in CCAAT/enhancer binding protein β (C/EBPΒ) is required for the glucocorticoid-mediated displacement of histone deacetylase 1 (HDAC1) from the C/ebpα promoter and maximum adipogenesis.
Abdou HS; Atlas E; Haché RJ
Endocrinology; 2013 Apr; 154(4):1454-64. PubMed ID: 23456364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
